Impact of tumor‐specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA‐containing nanoparticles
Year: 2007
Type: article
Source: Biotechnology and Bioengineering
DOI: 10.1002/bit.21668
Authors: Derek W. Bartlett, Mark E. Davis
Institution: California Institute of Technology
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2163276935
